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Abstract 
Up to date, the sufficient-component cause model seems to be
a theoretical framework for disease causation in epidemiology,
and its implications in epidemiological research methods is cur-
rently still limited. Recently, pitfalls in current epidemiological
research methods were addressed based on the sufficient-compo-
nent cause model; hence, new research approaches are needed as
alternatives. Therefore, this paper aims to review and suggest new
epidemiological methods used to assess disease causation. A new
approach was discussed to identify potential mechanisms of dis-
ease occurrence which may be useful for risk prediction and dis-
ease prevention. In addition, a novel “exposed case-control”
design was introduced to identify potential component causes.
Furthermore, this paper suggested a new approach of conducting
a systematic review/meta-analysis related to causation studies. 
Introduction
In the 1970s, Rothman introduced one of the most discussed
causal models in epidemiology. According to this model, suffi-
cient cause for an outcome is determined by a set of minimal con-
ditions and events that inevitably produce the stated outcome.1
This implies that all of the minimal conditions or events are nec-
essary for the outcome to occur.1,2 Each component cause is there-
fore a necessary part of the causal mechanism it contributes to; in
other words, no one factor is stronger than any of the others. A
specific component cause may play a role in one, two or more suf-
ficient causes. A component which is present in all sufficient caus-
es is known as a necessary cause. For example, if A in Figure 1
represents smoking in causing lung cancer, then the factors acting
with it in various causal mechanisms are the complementary fac-
tors for smoking in producing lung cancer. In disease causation,
most identified component causes are neither necessary nor suffi-
cient to cause a disease by themselves.2 
Nevertheless, diseases may be caused by either a few or many
sufficient causes, while each sufficient cause may also include
either a few or many individual components. Different component
factors may act at different times, and some may not be known or
cannot be expected, making it difficult to anticipate a specific
causal mechanism. However, these are not limitations to the suffi-
cient-component cause model, but merely indicate the overall
complexity of disease causation.3 Fortunately, outcomes can be
controlled by regulating common components in shared sufficient
causes.2 Despite certain limitations, 4 the sufficient-component
cause model seems to successfully explain some of the real-world
questions that could not be answered by previously held theories.3
Classical research methods used to assess disease
causation
Different study designs are often utilised in the scientific liter-
ature to assess disease associations and causation, including cross-
sectional, case-control, cohort and experimental designs.5,6
Among these, prospective cohort and experimental studies are
thought to be the optimal designs in causation research, due to
their ability to establish temporality and yield high quality data.5,6
However, experimental study designs are usually restricted by
costs and ethics, particularly when it comes to assessing disease
causation.2 In such designs, Relative Risk (RR) or Odds Ratio
(OR) as an approximation of RR, as well as the risk difference are
the most important measures of effect that are usually reported. 
Despite the wide utilization of the classical causation research
methods in the literature, pitfalls in those methods were addressed
in a recently published article.3 The addressed pitfalls were all
based on the sufficient-component cause model, suggesting the
need for alternative research approaches.3 At present, the suffi-
cient-component cause model is still considered as a theoretical
framework in the field of epidemiology.3,7 In other words, incor-
poration of the implications of the sufficient-component cause
model in current epidemiological research is rare. In this regard,
only one article could be retrieved in the literature that used a new
research approach based on this model.8 In addition, up-to-date,
no epidemiological research methods have been introduced to
study potential component causes that may act together in com-
mon sufficient causes. Studying such entities is very important in
disease prevention, risk prediction and personalized medicine.
Therefore, the current paper aims to review and suggest alterna-
tive research methods in the field of disease causation that are
based on this model. These suggestions are open to constructive
criticisms and may hopefully serve as the basis for further ideas in
this area.
PERSPECTIVES AND DEBATES
Significance for public health
This paper presented several novel epidemiological research approaches based on the sufficient-component cause model. The new approaches are of great
importance in disease prediction and prevention, and precision medicine. Therefore, the future use of the suggested new epidemiological methods in the area
of medicine and public health is promising.
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Causation research approaches based on the suffi-
cient-component cause model
Although the sufficient-component cause model was intro-
duced since long time, literature review revealed only one article
used a new research approach that was based on the model. In this
regard, Reiber et al. attempted to determine potential sufficient
causes for lower-extremity ulcers among diabetic patients.8 In this
approach, Reiber et al. predefined specific potential mechanisms
(sufficient causes) that can lead to lower-extremity ulcers, and then
in a group of cases with ulcers they studied which mechanism was
the most likely cause in each case. Although the approach used in
Reiber et al.’s study is subject to certain limitations, it was success-
ful in inspiring new ideas to advance methods in disease causation
research. However, disease prevention can be achieved by control-
ling common factors that play a shared role in sufficient causes of
a disease; as such there is no urgent need to identify potential suf-
ficient causes.2 
As mentioned previously, it is very difficult to anticipate or
suggest a likely sufficient cause in individual patients without a
reference comparison because there may be hundreds of sufficient
causes for an outcome, of which each may include many different
component causes which may in turn be unknown or unexpected
or act at different times. Although sufficient causes can be grouped
into overall classes (e.g. all sufficient causes that are related to
smoking are included within a smoking class),7 it is still difficult to
determine if an outcome is due to a specific class as the actual dis-
ease process is unknown and may be due to a sufficient cause that
is unexpected and far removed from the expected mechanism.  
Consider an example scenario of a 70-year-old patient with
lung cancer who has smoked 10 cigarettes/day for 5 years, along
with other factors thought to fit the disease mechanism. In this
case, the lung cancer could surprisingly be due to exposure to an
environmental substance during a one-week holiday the patient
had taken five years previously, along with other component caus-
es that fit a separate sufficient cause. Hence, the patient’s smoking
status and age may have nothing to do with the disease. In fact,
assuming that smoking class sufficient cause is the more likely
mechanism for lung cancer in this patient without a reference com-
parison may be due to a preoccupation with the role of smoking in
current lung cancer research.
Novel causation research approaches based 
on the sufficient-component cause model
Modified Reiber et al.’s approach 
In fact, Reiber et al.’s approach can be considered as the begin-
ning for innovating new epidemiological methods. In this article,
we suggest a modified version of Reiber et al.’s approach. The sug-
gestion is to involve a comparable control group who do not have
the outcome along with the case group. In exactly the same way as
for the case subjects, each individual in the control group should
be assessed for the presence of any possible combination of com-
ponent causes that may fit a likely sufficient cause. Assessors
should be as blinded as possible to the outcome; this can be easily
achieved in the previous example of lower-extremity ulcers by
applying the same wound dressing to the feet of all individuals in
both the case and control groups. However, in this type of study
design, it would not be fair to compare the proportion of individu-
als with a specific suggested sufficient cause/mechanism among
both cases and controls, as per the usual method. This is because
the sufficient-component cause model states that the sufficient
cause inevitably produces the outcome; therefore, the presence of
a suggested sufficient cause in a few individuals in the control
group is sufficient to exclude the mechanism. Accordingly, it will
be very challenging to come to valid conclusions. However, this
can be dramatically overcome by using big data studies and
Machine-Learning analytic programs.9,10 Another way to improve
this approach is to let Machine Learning computer program to
build algorithms (potential mechanisms) instead of assessing pre-
defined specific mechanisms for the outcome. In addition, the
Modified Reiber et al. approach is considered as a case-control
design, in which data quality is threatened. However, this can be
improved by using a prospective study design. Hopefully, the
future of big data held by Machine-Learning software to build
algorithms for predicting disease occurrence, using the modified
Reiber et al. approach, is promising.
Exposed case-control study design 
Instead, a new alternative approach suggested in this paper, is
to identify likely common complementary component causes that
act in common sufficient causes of a specific factor in producing a
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Figure 1. Three sufficient causes of an outcome. Each pie (a sufficient cause) consists of specific factors. Each of the letters A, B, C, etc.










specific disease/outcome. For example, if we can identify common
complementary factors for smoking in causing lung cancer, then it
would be of a great benefit. This may be useful in planning alter-
native preventative measures for individuals who are exposed to a
certain factor which cannot easily be controlled at either the popu-
lation or individual levels. This may also be applicable for other
causation studies including therapeutic studies where a certain
agent (e.g. drug) is tested. In this regard, if we can identify com-
plementary factors that act with the studied agent in causing cure
or any other favourable outcome, then this would be of a great
importance in precision medicine. 
For this purpose, cohort studies or experimental studies (if fea-
sible) which yield large RR or OR values are needed. In this
regard, in the studies that identify larger RR values for a factor (or
intervention), the exposed groups have a larger proportion of out-
come cases attributable to that factor’s sufficient causes, compared
to study samples with lower RR values, provided that the exposed
and unexposed groups are comparable.3 In other words, in samples
with a higher RR value, the availability of complementary factors
is greater. Therefore, we may label study samples which determine
a large RR for a specific factor as “golden samples”, and exposed
groups in such studies deemed to be “golden exposed groups”.
While there is no exact cut-off RR value for golden samples, we
consider a RR value of >2.0 as a reasonable limit, at which more
than 50% of outcome cases in the exposed group are attributable to
the studied factor. However, studies with larger RR values are
preferable and their findings should be given more weight and
attention. It is important to note that exposed and unexposed
groups in a study should be comparable in order to deem the sam-
ple to be golden. Subsequently, potential common component
causes in golden samples can be identified at two levels: the study
sample level and stratification subgroup level. 
At the study sample level, cases in a golden exposed group (i.e.
golden cases) should be given special attention to further identify
potential complementary characteristics that might act together
with the factor of interest. Golden cases in which the outcome
manifested should be compared to the exposed subjects who did
not develop the outcome in the same golden group. Simply put, the
characteristics of exposed outcome cases should be studied and
compared to those of exposed control subjects who remained free
of the outcome. The revealed unique characteristics should be con-
sidered as potential complementary factors for the factor under
study. This new design may be called an “exposed case-control
study design”. Figure 2 shows the basic framework of this new
design considering smoking and lung cancer as examples of expo-
sure and outcome respectively.
In such a design, the exposed cases and exposed controls can
be nested from a cohort study (as discussed above), however,
exposed cases and exposed controls can be selected from general
populations or from hospital settings, as the case in the classical
case-control studies. However, exposed cases and controls nested
from cohort studies with large RR are better due to higher chance
that the cases are attributed to the studied exposure. 
Beforehand, if possible, “filtering” of the outcome cases in the
golden group should be attempted, so that if we can remove at least
some cases (from the golden cases) that are likely to be caused by
other sufficient causes (that do not belong to the factor of interest),
then we may end with golden cases that are more likely to be
caused by sufficient causes that belong to the studied factor. This
is because there is a baseline proportion of outcome cases in the
golden exposed group that are thought to be caused by sufficient
causes related to other factors.3 The filtering of golden cases can
be performed using a “best-matching” method. In this approach,
outcome cases that arise in the unexposed group (baseline cases)
are matched according to their characteristics and risk factor pro-
file as closely as possible to golden cases, either by means of sta-
tistical software or manually. The assumption here is that a case in
the golden group that appears very similar (in terms of its potential
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Figure 2. Basic framework for the exposed case-control design used to identify common complementary factors acting with a specific
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risk factors and characteristics) to one or more cases in the unex-
posed group is likely to be caused by sufficient causes of other fac-
tors and not the factor of interest, thus representing baseline cases.
While it is not necessary to find matching cases for all suspected
baseline cases, removing a few from among the golden cases is
worthwhile. Once filtered, golden cases should then be compared
to exposed subjects who did not develop the outcome, as an
attempt to identify some of the potential complementary factors
acting with the studied factor. Results revealed by such studies
may then be compared or compiled later on during a systematic
review/meta-analysis, as discussed later in this paper.
At the second level, the stratification level, the RR value
observed for a factor in a golden sample is further studied in sub-
groups (strata) related to other stratifying factors in a similar
method to that classically used to identify confounding factors.
Stratifying factors should be selected with caution and may include
risk factors as well as potential confounders. This method allows
for the analysis of likely confounding, intermediate and comple-
mentary factors. If the exposed and unexposed subgroups in each
stratum are comparable, then the following possibilities should be
considered. If the RR value is insignificant in all strata, then the
stratifying factor may be a confounder or an intermediate factor. If
all strata show significant RR values, then the factor being studied
is independent of the stratifying factor in producing the outcome.
However, in this case, sufficient causes that share both factors may
still exist. If the RR value is significant for some strata only, then
it is likely that the factor of interest and the risky level of the strat-
ifying factor which reveal a significant RR value are components
in common sufficient causes. In the latter two situations, the
exposed subgroups (strata) that yield larger significant RR values
for the studied factor have a higher availability of complementary
factors acting together with the factor of interest. Similar to golden
samples, such are deemed golden subgroups because a larger pro-
portion of the outcome cases can be attributed to the studied fac-
tor’s sufficient causes compared to subgroups with smaller RR val-
ues. Therefore, golden cases in these exposed subgroups at the
stratification level are known as golden cases. Moreover, the out-
come cases arising in such subgroups should undergo further anal-
ysis for characteristics thought to act together with the factor of
interest.
A golden subgroup should only be labelled as “golden” if it is
comparable to its control subgroup in the stratification analysis. As
for the study sample level, filtering golden outcome cases in the
golden subgroup at the stratification level would likewise be
worthwhile, in the same way and for the same reason as previously
explained. To this end, outcome cases that arise in the unexposed
subgroup in the same strata should be matched according to their
key characteristics with outcome cases in the golden case sub-
group. Thereafter, a golden case that appears very similar (in terms
of its potential risk factors and characteristics) to one or more cases
in the unexposed subgroup should be excluded. Once again, the
removal of even a few suspected cases is advantageous.
As before, the remaining golden cases should then be com-
pared to other subjects within the exposed subgroup, who did not
develop the outcome, so as to identify unique characteristics of
golden outcome cases. This process should then be repeated for
other subgroups according to other stratifying factors.
Subsequently, results revealed by different studies would then be
more useful for subsequent systematic reviews/meta-analyses.
However, if the strata subgroups are not comparable, then the
revealed potential characteristics may be used to form a working
hypothesis which can then be confirmed or disproved in subse-
quent studies.
For example, if the RR value of current smoking status in pro-
ducing a lung cancer outcome in a golden cohort sample is
observed to be highest among obese patients, and the smoker obese
subgroup is comparable to its control subgroup (i.e. non-smoker
non-obese individuals), then the smoker obese subgroup can be
considered a golden subgroup and the outcome cases as golden
cases. After filtering is attempted, the characteristics of golden
cases can be compared to those of obese smokers who did not
develop lung cancer in order to identify their unique potential char-
acteristics. While the smoker obese subgroup cannot be called a
golden subgroup if it is not comparable to its control subgroup,
studying the unique characteristics of non-comparable subgroup
cases can nevertheless be performed in a similar way; however, as
mentioned previously, findings from such comparisons cannot be
used to draw firm conclusions but should be used as the basis of a
hypothesis to be investigated in further studies. Furthermore, the
same analytic process should be undertaken using other stratifying
factors.
It is important to note that this new method is subject to certain
limitations, as it is built on assumptions and conditions which are
often not that easy to assess or meet. For instance, it is relatively
uncommon to find a sample with a RR value of 3-4 or higher, how-
ever, samples with smaller RR are still valuable. In addition, ensur-
ing comparability between groups can be challenging especially in
stratification subgroup analysis. However, studies with big data is
the key to get comparable stratification subgroups for such analy-
sis. Moreover, the concept of an additional filtering step can be a
‘double-edged sword’. However, most current research methods
and statistical approaches are also based on similar assumptions,
with each method subject to specific advantages and disadvan-
tages. Simply, we have no other perfect way when dealing with the
unseen. 
New approach to systematic review/meta-analysis 
Another methodological issue is related to systematic
reviews/meta-analyses. It seems that the use of the classical
approach of conducting systematic review/meta-analysis is threat-
ened.3,11 It seems that mixing studies that address specific expo-
sure and showing different results in different populations in order
to measure the net effect is unreasonable.3 There is no point in let-
ting different studies in different populations averaging the effect
of each other since the prevalence of complementary factors for the
studied exposure differ in different populations.3 Therefore, the
observed RRs (or OR) in different good quality studies that involve
different populations are independent of each other and therefore,
all should be assumed to be true for their samples. An example of
such a classical meta-analysis is the one conducted by Aune et al.
to investigate the association between total meat intake and type 2
diabetes risk.12 In this classical meta-analysis, the overall effect
shown in the net RR suggests no association. However, taking in
consideration that the availability of complementary factors of
meat consumption differ in different populations, meat consump-
tion seems to be a significant risk factor in some populations and
seems a protective factor in others, as it is obvious in the forest
plot. However, this variability in the effect of this factor has disap-
peared by analyzing the net effect that shows no difference, which
is a misleading result. The classical net effect that showed no asso-
ciation may lead to ignore this factor in the affected populations.
Therefore, novel approaches related to methods of conducting
systematic reviews/meta-analyses related to causation studies are
discussed here. First, this research design may be used to assess the
likely existence of a factor’s sufficient causes - and hence to deter-
mine if there is an overall relationship between the factor (or agent)
of interest and an outcome - after the factor has been studied in dif-
ferent samples. For this purpose, high-quality studies among dif-










ferent populations whose primary purpose is to study the factor of
interest should be included. Most importantly, included studies
should ensure the comparability of the exposed and unexposed
groups. Conversely, the clinical heterogeneity (variability in the
study setting and participants across studies), statistical hetero-
geneity (variability in the results) and representativeness of the
samples are not important criteria of the inclusion of the studies in
such a systematic review/meta-analysis. In this regard, without
analysing the classical net effect, if some high-quality studies have
indicated the likely existence of a factor’s sufficient causes (in the
form of a significant RR or OR value or risk difference), then it can
be concluded that there is a likely association between the factor of
interest and the outcome. Due to the possibility of bias and poor
academic integrity in which poor-quality data are falsely reported
to be of good quality, such conclusions cannot be based on a single
study. However, if several high-quality studies among diverse pop-
ulations have indicated no association, with no conflicting results,
then it is equally possible that i) there is no association between the
factor and the outcome or ii) that the prevalence of the factor’s suf-
ficient causes in the studied samples/populations is rare.3 In such
situations, it is preferable to interpret such results as indicative of
no observed association to date.  Second, a systematic
review/meta-analysis can be used to assess the contribution of a
factor of interest in causing the outcome of interest within a specif-
ic population. This can be assessed by estimating the likely preva-
lence of a factor’s sufficient causes within the exposed group (risk
difference) or the related population (population-attributable
risk).3 Different studies of the same population may reveal differ-
ent findings due to variations in the representativeness of the cho-
sen samples, study designs and quality of data, as well as differ-
ences in the characteristics of each sample. Therefore, the popula-
tion must be as specific as possible so that samples share at least
certain key characteristics such as, but not limited to, ethnicity,
lifestyle and culture. Hence, high-quality studies conducted among
the same population should be included within such analysis, and
the representativeness should be one of the most important criteria
utilised to include/exclude various studies. Studies in which the
exposed or unexposed group is not representative of the chosen
population (apart from the factor of interest) must be excluded
because in this case the risk difference does not represent the
prevalence of the factor’s sufficient causes in the exposed popula-
tion, and the calculated population attributable risk does not repre-
sent the prevalence of the factor’s sufficient causes within the total
population.3 Notably, the clinical homogeneity of included studies
is important, while statistical heterogeneity is not. As such, the
prevalence of the factor’s sufficient causes among the exposed
population (risk difference) is averaged based on sample size and
hence the likely population attributable risk (i.e. the prevalence of
the factor’s sufficient causes within the population) can be calcu-
lated by multiplying the averaged risk difference in the prevalence
of that factor within the total population.3
More importantly, systematic reviews/meta-analyses should be
used to study the unique characteristics (i.e. the potential comple-
mentary factors acting together with the factor of interest) observed
for golden cases in different studies, at both the study sample and
stratification levels (as discussed in a former part of this article).
However, studies with higher RR or OR values should be given
more weight, while the clinical and statistical homogeneity are not
important criteria for the inclusion of studies. In such analysis, stud-
ies conducted in different settings and showing different results are
required to reach valid conclusions. As a result of critically compar-
ing the results of included studies, the analysis may yield important
conclusions related to common complementary factors acting with a
specific factor. Later on, different meta-analysis conducted to assess
complementary factors for different classes of sufficient causes may
be included in one big analysis to identify common complimentary
factors acting in different classes of sufficient causes. For example,
after studying complementary factors for smoking and complemen-
tary factors for obesity (each in a separate meta-analysis), then we
can identify the common complementary factors acting with both
exposures. This will be of a great value in epidemiology and preven-
tive medicine. Additionally, systematic reviews/meta-analyses may
be used to compare the distribution of different classes of sufficient
causes in various populations. While this is similar to the classical
method of approaching a systematic review/meta-analysis, the aim
here is not to study the net averaged effect (e.g. net RR or OR) which
is thought to be meaningless,3,11 but to compare the prevalence of a
factor’s sufficient causes within different exposed populations (risk
differences) and their prevalence in the total populations (popula-
tion-attributable risk),3 revealed by different studies in diverse pop-
ulations. However, the usefulness of such a review is questionable
since different populations are independent of each other.
Conclusions 
For the first time in literature, this paper sought to suggest sev-
eral promising new research approaches based on the sufficient-
component cause model. A new approach was discussed to identify
potential mechanisms of disease occurrence which may be useful
for risk prediction purposes. In addition, a novel suggestion was
made to identify potential component causes in common sufficient
causes by focusing on “golden” cases using a novel “exposed case-
control” study design. Furthermore, due to the threatened classical
systematic review/meta-analysis approach, an alternative approach
of conducting a systematic review/meta-analysis was introduced.
Future research may be conducted to verify and utilize the newly
suggested approaches.
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